JPMORGAN CHASE & CO - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$27,075,384
+15.2%
32,900
+0.6%
0.00%0.0%
Q2 2023$23,496,258
-83.2%
32,700
-80.8%
0.00%
-82.4%
Q1 2023$139,602,000
+895703.4%
169,900
+686.6%
0.02%
+750.0%
Q4 2022$15,584
-95.5%
21,600
+4220.0%
0.00%
Q3 2022$344,000
+16.2%
5000.0%0.00%
Q2 2022$296,000
-15.2%
5000.0%0.00%
Q1 2022$349,000
+56.5%
500
+25.0%
0.00%
Q2 2021$223,000
-97.0%
400
-97.4%
0.00%
-100.0%
Q4 2020$7,488,000
-15.8%
15,5000.0%0.00%0.0%
Q3 2020$8,891,000
-8.0%
15,5000.0%0.00%
-50.0%
Q2 2020$9,667,000
+27.7%
15,5000.0%0.00%0.0%
Q1 2020$7,568,000
-10.8%
15,500
-31.4%
0.00%0.0%
Q4 2019$8,486,000
+27.5%
22,600
-5.8%
0.00%
+100.0%
Q3 2019$6,658,000
-0.3%
24,000
+11.6%
0.00%0.0%
Q2 2019$6,679,000
+22.3%
21,500
+61.7%
0.00%0.0%
Q1 2019$5,461,000
-91.9%
13,300
-92.6%
0.00%
-93.8%
Q4 2018$67,230,000
+88.2%
180,000
+103.6%
0.02%
+128.6%
Q3 2018$35,717,000
+11.3%
88,400
-4.9%
0.01%0.0%
Q2 2018$32,084,000
+4.3%
93,000
+4.1%
0.01%0.0%
Q1 2018$30,751,000
+25.1%
89,300
+36.5%
0.01%
+40.0%
Q4 2017$24,588,000
+3.1%
65,400
+19.3%
0.01%0.0%
Q3 2017$23,844,000
+405.7%
54,800
+470.8%
0.01%
+400.0%
Q2 2017$4,715,000
-28.0%
9,600
-43.2%
0.00%0.0%
Q1 2017$6,549,00016,9000.00%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 56,500$33,399,0000.05%
JANE STREET GROUP, LLC 100,400$59,349,0000.02%
SIMPLEX TRADING, LLC 12,000$7,093,0000.01%
JPMORGAN CHASE & CO 500$296,0000.00%
Allianz Asset Management GmbH 600$355,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders